Vericel Q1 revenue rises 30% to $68.4 million; full-year revenue guidance raised
Vericel reported first quarter 2026 total revenue of $68.4 million, up 30% from $52.6 million a year earlier, and its net loss narrowed to $6.3 million, or $0.12 per diluted share, from $11.2 million, or $0.23 per share. The company raised its full-year 2026 total revenue guidance to $326 to $336 million from $316 to $326 million, which signals higher expected sales for shareholders.
Key points
- Total revenue of $68.4 million, up 30% from $52.6 million in the first quarter of 2025
- Net loss of $6.3 million, or $0.12 per diluted share, compared with $11.2 million, or $0.23, a year earlier
- Full-year 2026 total revenue guidance raised to $326 to $336 million; Burn Care guidance raised to $44 to $48 million from $36 to $40 million
- Free cash flow of $15.1 million; approximately $211 million in cash and investments and no debt
The filing
Written by AI on Nov 8, 2026, 1:49 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 07, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.